Artificial intelligence is helping doctors and nurses save time and see more patients. However, a Philips survey shows most healthcare work...

In 1907, what began as a manufacturing mishap morphed into the revolutionary invention of paper towels. The unexpected resilience of tissue...

British drug giant GSK is reportedly in talks to acquire cancer drugmaker Nuvalent. The deal could be worth over nine billion dollars. Disc...

Elon Musk brain chip Neuralink competitor: China has approved the world's first brain-computer chip, NEO, for commercial sale after complet...

Viyash Scientific, backed by Carlyle, is acquiring Italy's BioForLife for Rs. 188 crore. This move aims to build a leading global companion...

Hexagon Nutrition’s Rs 139 crore IPO saw strong retail demand on Day 2, with the retail portion subscribed 2.43 times. The grey market prem...

Originally developed to address eye disorders such as blepharospasm, Botox has evolved into a key player in the cosmetic industry since its...

A new blood test can predict lung cancer more than five years before diagnosis. This breakthrough offers hope for early detection in India....

Brij and Sunita Agarwal have gifted USD 5.5 million to expand medical services in Houston. This significant donation will enhance clinical ...

Eastern Congo faces a rapid Ebola outbreak. Women are primary caregivers, increasing their infection risk. Many lack protective gear, forci...

The Delhi High Court has asked the Central Drugs Standard Control Organisation to review a petition challenging Zydus Lifesciences' approva...

Serum Institute of India will produce clinical trial doses of a new Ebola vaccine from Oxford University. This initiative is backed by fres...

GVK family-backed Oval Fertility has launched its first premium IVF center in Hyderabad, leveraging advanced embryo monitoring technology. ...

Founded in 2024, KorinMi is a Korean beauty clinic that started with skin treatments and has now expanded to direct-to-consumer (D2C) produ...

Toregem BioPharma has secured $5.3 million to advance its experimental tooth-regeneration drug, TRG035, into Phase II clinical trials. The ...

A rare Bundibugyo virus outbreak in Congo, with over 200 deaths, lacks specific treatments or vaccines, complicating response efforts. Whil...

South Korea is attracting a growing number of foreign visitors for advanced skincare treatments. Tourists are spending more on medical serv...